Hannah’s practice focuses on capital markets transactions, SEC reporting, corporate governance, and general corporate counseling for emerging growth technology and life sciences companies. She advises issuers and other market participants on compliance with federal securities laws and stock exchange requirements, as well as on ongoing disclosure, reporting obligations, and corporate governance best practices.

She also counsels clients on a variety of public and private securities offerings, including initial public offerings and follow-on offerings, and supports boards of directors and management teams in navigating complex transactional, regulatory, and disclosure issues. Hannah’s background in health management and policy, together with her prior experience in insurance and regulated industries, informs her practical, business-focused approach to advising clients operating in highly regulated markets.